share_log

In8bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

SEC announcement ·  Jan 19 00:00
Summary by Moomoo AI
In8bio, Inc., a biotechnology company based in New York, has filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) on January 19, 2024. The filing is intended to register additional shares for the company's employee benefit plans, specifically 400,000 shares for the 2020 Employee Stock Purchase Plan and 2,164,366 shares for the Amended and Restated 2023 Equity Incentive Plan. These registrations are in line with the provisions for annual automatic increases in the number of shares reserved for issuance under each plan. The company has incorporated by reference several previously filed documents with the SEC, including past Registration Statements, Annual Reports, Current Reports, and Quarterly Reports. In8bio has also confirmed its indemnification agreements with directors and officers, ensuring protection to the fullest extent permitted by law, and maintains insurance policies for indemnification against various liabilities. The company has not claimed any exemption from registration and has listed the exhibits related to the Registration Statement.
In8bio, Inc., a biotechnology company based in New York, has filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) on January 19, 2024. The filing is intended to register additional shares for the company's employee benefit plans, specifically 400,000 shares for the 2020 Employee Stock Purchase Plan and 2,164,366 shares for the Amended and Restated 2023 Equity Incentive Plan. These registrations are in line with the provisions for annual automatic increases in the number of shares reserved for issuance under each plan. The company has incorporated by reference several previously filed documents with the SEC, including past Registration Statements, Annual Reports, Current Reports, and Quarterly Reports. In8bio has also confirmed its indemnification agreements with directors and officers, ensuring protection to the fullest extent permitted by law, and maintains insurance policies for indemnification against various liabilities. The company has not claimed any exemption from registration and has listed the exhibits related to the Registration Statement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Doc 3

Doc 4

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more